Santiago Arroyo
Director/Board Member chez H. LUNDBECK A/S
Fortune : 971 100 $ au 31/03/2024
Profil
Actuellement, Santiago Arroyo occupe le poste de directeur médical et de vice-président principal du développement chez Momenta Pharmaceuticals, Inc. Le Dr Arroyo siège également au conseil d'administration de H. Lundbeck A. Auparavant, le Dr Arroyo a occupé les postes de chef des services médicaux - biothérapeutique chez Pfizer Inc. et Boston Pharmaceuticals, Inc., de chef des neurosciences et de la médecine de découverte chez Bristol Myers Squibb Co. et de chef du développement clinique mondial chez Eisai Co. Ltd. ainsi que de professeur associé à l'hôpital Clnic de Barcelone et de professeur associé au Medical College of Wisconsin, Inc. Santiago Arroyo a obtenu un doctorat de l'Universidad Autnoma de Madrid et un doctorat de l'Université de Barcelone.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
06/02/2024 | 39 000 ( 0,13% ) | 971 100 $ | 31/03/2024 |
Postes actifs de Santiago Arroyo
Sociétés | Poste | Début |
---|---|---|
H. LUNDBECK A/S | Director/Board Member | 23/03/2021 |
BICYCLE THERAPEUTICS PLC | Corporate Officer/Principal | 31/03/2023 |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Director/Board Member | 02/05/2023 |
Anciens postes connus de Santiago Arroyo
Sociétés | Poste | Fin |
---|---|---|
MARINUS PHARMACEUTICALS, INC. | Director/Board Member | 13/11/2022 |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01/05/2017 |
PFIZER, INC. | Chief Tech/Sci/R&D Officer | 01/10/2015 |
EISAI CO., LTD. | Corporate Officer/Principal | 01/01/2007 |
Hospital Clínic de Barcelona
Hospital Clínic de Barcelona Hospital/Nursing ManagementHealth Services Hospital Clínic de Barcelona is a healthcare company based in Barcelona, Spain. The Spanish company operates a website for Hospital Clínic and IDIBAPS. The CEO of the private company is Josep Maria Campistol. | Corporate Officer/Principal | 01/01/2003 |
Formation de Santiago Arroyo
University of Barcelona | Doctorate Degree |
Universidad Autónoma de Madrid | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 7 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
PFIZER, INC. | Health Technology |
EISAI CO., LTD. | Health Technology |
H. LUNDBECK A/S | Health Technology |
MARINUS PHARMACEUTICALS, INC. | Health Technology |
BICYCLE THERAPEUTICS PLC | Health Technology |
FULCRUM THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Hospital Clínic de Barcelona
Hospital Clínic de Barcelona Hospital/Nursing ManagementHealth Services Hospital Clínic de Barcelona is a healthcare company based in Barcelona, Spain. The Spanish company operates a website for Hospital Clínic and IDIBAPS. The CEO of the private company is Josep Maria Campistol. | Health Services |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Commercial Services |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Health Technology |